BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7591506)

  • 1. Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease.
    Mielke R; Kessler J; Fink G; Herholz K; Heiss WD
    Int J Neurosci; 1995 May; 82(1-2):1-9. PubMed ID: 7591506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
    Kessler J; Herholz K; Grond M; Heiss WD
    Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
    Szelies B; Mielke R; Grond M; Heiss WD
    J Neurol Sci; 1995 May; 130(1):77-81. PubMed ID: 7650534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
    Mielke R; Herholz K; Grond M; Kessler J; Heiss WD
    Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation in the premotor cortex during mental calculation in patients with Alzheimer's disease: relevance of reduction in posterior cingulate metabolism.
    Ouchi Y; Yoshikawa E; Futatsubashi M; Okada H; Torizuka T; Kaneko M
    Neuroimage; 2004 May; 22(1):155-63. PubMed ID: 15110005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual versus auditory memory stimulation in patients with probable Alzheimer's disease. A PET study with 18 FDG.
    Kessler J; Ghaemi M; Mielke R; Herholz K; Heiss WD
    Ann N Y Acad Sci; 1996 Jan; 777():233-8. PubMed ID: 8624090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
    Benson DF; Kuhl DE; Hawkins RA; Phelps ME; Cummings JL; Tsai SY
    Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R; Heiss WD
    J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparability of FDG PET studies in probable Alzheimer's disease.
    Herholz K; Perani D; Salmon E; Franck G; Fazio F; Heiss WD; Comar D
    J Nucl Med; 1993 Sep; 34(9):1460-6. PubMed ID: 8355064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET.
    Mentis MJ; Horwitz B; Grady CL; Alexander GE; VanMeter JW; Maisog JM; Pietrini P; Schapiro MB; Rapoport SI
    Am J Psychiatry; 1996 Jan; 153(1):32-40. PubMed ID: 8540589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease.
    Heiss WD; Kessler J; Slansky I; Mielke R; Szelies B; Herholz K
    Ann N Y Acad Sci; 1993 Sep; 695():327-31. PubMed ID: 8239307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIH Conference. Brain imaging: aging and dementia.
    Cutler NR; Duara R; Creasey H; Grady CL; Haxby JV; Schapiro MB; Rapoport SI
    Ann Intern Med; 1984 Sep; 101(3):355-69. PubMed ID: 6235763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
    Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease.
    Mielke R; Ghaemi M; Kessler J; Kittner B; Szelies B; Herholz K; Heiss WD
    J Neurol Sci; 1998 Jan; 154(1):76-82. PubMed ID: 9543326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease.
    Valladares-Neto DC; Buchsbaum MS; Evans WJ; Nguyen D; Nguyen P; Siegel BV; Stanley J; Starr A; Guich S; Rice D
    Neuropsychobiology; 1995; 31(4):173-81. PubMed ID: 7659198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
    Minoshima S; Giordani B; Berent S; Frey KA; Foster NL; Kuhl DE
    Ann Neurol; 1997 Jul; 42(1):85-94. PubMed ID: 9225689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.